These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34743989)

  • 1. Expression of GALNT8 and O-glycosylation of BMP receptor 1A suppress breast cancer cell proliferation by upregulating ERα levels.
    Huang T; Wu Q; Huang H; Zhang C; Wang L; Wang L; Liu Y; Li W; Zhang J; Liu Y
    Biochim Biophys Acta Gen Subj; 2022 Jan; 1866(1):130046. PubMed ID: 34743989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GALNT8 suppresses breast cancer cell metastasis potential by regulating EGFR O-GalNAcylation.
    Huang T; Meng F; Huang H; Wang L; Wang L; Liu Y; Liu Y; Wang J; Li W; Zhang J; Liu Y
    Biochem Biophys Res Commun; 2022 Apr; 601():16-23. PubMed ID: 35220009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A.
    Yang Y; Ding M; Yin H; Chen W; Shen H; Diao W; Yang L; Qin H; Gan W; Qiu X; Guo H
    Int J Biol Sci; 2024; 20(4):1297-1313. PubMed ID: 38385080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GalNAc-T4 putatively modulates the estrogen regulatory network through FOXA1 glycosylation in human breast cancer cells.
    Niang B; Jin L; Chen X; Guo X; Zhang H; Wu Q; Padhiar AA; Xiao M; Fang D; Zhang J
    Mol Cell Biochem; 2016 Jan; 411(1-2):393-402. PubMed ID: 26541755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines.
    Wang D; Huang P; Zhu B; Sun L; Huang Q; Wang J
    Mol Med Rep; 2012 Sep; 6(3):591-6. PubMed ID: 22711074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
    Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
    Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.
    Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H
    J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.
    Liu Y; Zhang RX; Yuan W; Chen HQ; Tian DD; Li H; Jiang X; Deng ZL; Wang Y
    Cell Physiol Biochem; 2018; 45(5):1759-1771. PubMed ID: 29495003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
    Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
    Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development.
    Pan H; Zhang H; Abraham P; Komatsu Y; Lyons K; Kaartinen V; Mishina Y
    Dev Biol; 2017 Sep; 429(1):260-270. PubMed ID: 28641928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective mesenchymal Bmpr1a-mediated BMP signaling causes congenital pulmonary cysts.
    Luo Y; Cao K; Chiu J; Chen H; Wang HJ; Thornton ME; Grubbs BH; Kolb M; Parmacek MS; Mishina Y; Shi W
    Elife; 2024 Jun; 12():. PubMed ID: 38856718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.
    Pickup MW; Hover LD; Guo Y; Gorska AE; Chytil A; Novitskiy SV; Moses HL; Owens P
    Oncotarget; 2015 Sep; 6(26):22890-904. PubMed ID: 26274893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
    Han L; Liu B; Jiang L; Liu J; Han S
    Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
    Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
    Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
    Thaler S; Schmidt M; Schad A; Sleeman JP
    Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
    Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the bone morphogenetic protein receptor by H11kinase/Hsp22 promotes cardiac cell growth and survival.
    Sui X; Li D; Qiu H; Gaussin V; Depre C
    Circ Res; 2009 Apr; 104(7):887-95. PubMed ID: 19246680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development.
    Edson MA; Nalam RL; Clementi C; Franco HL; Demayo FJ; Lyons KM; Pangas SA; Matzuk MM
    Mol Endocrinol; 2010 Jun; 24(6):1251-66. PubMed ID: 20363875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
    Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
    Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.